Results 191 to 200 of about 302,633 (354)

Trends and outcomes in the use of surgery and radiation for the treatment of locally advanced esophageal cancer: a propensity score adjusted analysis of the surveillance, epidemiology, and end results registry from 1998 to 2008 [PDF]

, 2013
Mathias Worni, Anthony W. Castleberry, Beat Gloor, Ricardo Pietrobon, John C. Haney, T. D’Amico, Igor Akushevich, Mark F. Berry   +7 more
openalex   +1 more source

Unveiling a New Link: Cholesterol Deficiency in Smith–Lemli–Opitz and Niemann–Pick C as a Driver of Ciliopathies

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT The ciliopathies are a group of genetic disorders caused by defective function of either the primary cilia (a large number) or the motile cilia (a much smaller number). These have been defined as diseases with mutations in genes encoding individual ciliary or cilia‐associated proteins.
Robert P. Erickson, Maria Teresa Fiorenza   +1 more
wiley   +1 more source

Saliva and blood miRNAs as complementary biomarkers for esophageal cancer detection. [PDF]

Front Oncol
Maxwell MK, Nonaka T.
europepmc   +1 more source

The Intensity of Radiotherapy-Elicited Immune Response Is Associated with Esophageal Cancer Clearance [PDF]

, 2014
Jinlu Ma, Long Jin, Yaodong Li, Chenchen He, Xijing Guo, Rui Liu, Yun-Yi Yang, Suxia Han   +7 more
openalex   +1 more source

Bioinformatics‐based discovery of the involvement of PSAT1 in mediating the anti‐lung adenocarcinoma activity of triptolide

Animal Models and Experimental Medicine, EarlyView.
Transcriptome sequencing was performed on tumor tissues from triptolide‐treated tumor‐bearing mice. The sequencing results were integrated with data from public databases for comprehensive analysis, and potential regulatory targets of triptolide were identified.
Zhiwen Cao, Lulu Zhang, Wenqiang Zhang, Rong Wan, Xiaogang Peng, Jinyan Xie, Ruru Bai, Jiejing Jin, Changqi Shi, Lan Yan, Xiangyu Guo, Yang Shen, Cheng Lu   +12 more
wiley   +1 more source

MicroRNAs in Esophageal Cancer: Implications for Diagnosis, Progression, Prognosis and Chemoresistance. [PDF]

Int J Mol Sci
Cataldi-Stagetti E, Governatori G, Orsini A, De Nicolo B, Zagari RM, Bonora E.   +5 more
europepmc   +1 more source

Current Advances in Immunotherapy Management of Esophageal Cancer [PDF]

Sagar Pyreddy, Sarah Kim, William Miyamoto, Zohray Talib, Dev GnanaDev, Amir A. Rahnemai‐Azar   +5 more
openalex   +1 more source

Aspirin acts in esophageal cancer: a brief review [PDF]

, 2018
Weiming Hao, Yaxing Shen, Mingxiang Feng, Hao Wang, Miao Lin, Yong Fang, Lijie Tan   +6 more
openalex   +1 more source

Nanoclay‐Engineered Scaffolds for the Controlled Delivery of Biomolecules in Regenerative Medicine

Asia-Pacific Journal of Chemical Engineering, EarlyView.
ABSTRACT Regenerative medicine combines biomaterials, cells, scaffolds, and bioactive agents via modern technologies to aid in the reconstruction and repair of damaged tissues. Among these, nanoclay scaffolds have demonstrated unique advantages in facilitating the delivery of therapeutic agents.
Mehri Shadi, Saeed Vafaei‐Nezhad, Ahmad Gholamalizadeh Ahangar   +2 more
wiley   +1 more source

Esophageal Cancer With Neurologically Symptomatic Parapharyngeal Space Paraganglioma. [PDF]

Clin Case Rep
Nozu S, Fukuda T, Shiomi S, Oka D, Shirakura S, Ushijima H.   +5 more
europepmc   +1 more source